More than 40 years have passed since the CDC reported the first cases of HIV in the United States. In that time, we’ve ...
Explore Gilead Sciences' Q3 2025 earnings: strong HIV portfolio growth, Yeztugo's rapid launch, and raised guidance.
"You know, it's not the best news. But there was other news that could have been a lot worse, you know?" Charlie Sheen said.
Gilead Sciences said on Thursday its HIV drug sales rose 4% to $5.3 billion in the third quarter including $39 million for ...
Gilead Sciences said on Thursday its HIV drug sales rose 4% to $5.3 billion in the third quarter including $39 million for ...
More than 230 people became infected with HIV in Indiana, worsened by delayed action from former Gov. Mike Pence. Experts and ...
Patrick and Charles Boyd bought more than $90 million of the illicit drugs and sold them to unwitting customers in South ...
We often encounter patients taking multiple medications, which complicates choosing safe and effective antimicrobial ...
Investor's Business Daily on MSN
Gilead Sciences Dives As HIV Drug Misses Bullish Buy-Side Expectations
Gilead stock slumped late Thursday on soft product sales and lighter-than-expected revenue from its newcomer HIV prevention ...
People who caught the flu were up to six times more likely to have a heart attack in the month after the infection.
5hon MSN
Vermont community organizations help fill need for LGBTQ resources during Pride Center pause
"We did what we had to do to make sure that we could reopen those services," said Em Russo with the SafeSpace program.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback